NASDAQ | ETF
The fund generally will invest at least 90% of its total assets in the securities that comprise the index.
Strictly in accordance with its guidelines and mandated procedures, Nasdaq compiles the underlying index, which is a modified market capitalization weighted index that is designed to measure the performance of securities listed on the Nasdaq Stock Market that are classified as either biotechnology or pharmaceutical companies.
The index may include securities of large-, mid- and small-capitalization companies.
The fund is non-diversified.
Top 20 Holdings
| Asset | Name | Sector | Industry | Weight |
|---|---|---|---|---|
| GILD | Gilead Sciences Inc | Healthcare | Drug Manufacturers - General | 8.57% |
| AMGN | Amgen Inc | Healthcare | Drug Manufacturers - General | 8.25% |
| VRTX | Vertex Pharmaceuticals Inc | Healthcare | Biotechnology | 7.71% |
| REGN | Regeneron Pharmaceuticals Inc | Healthcare | Biotechnology | 7.50% |
| AZN | AstraZeneca PLC ADR | Healthcare | Drug Manufacturers - General | 3.90% |
| ALNY | Alnylam Pharmaceuticals Inc | Healthcare | Biotechnology | 3.22% |
| ILMN | Illumina Inc | Healthcare | Diagnostics & Research | 2.18% |
| ARGX | argenx NV ADR | Healthcare | Biotechnology | 2.13% |
| BIIB | Biogen Inc | Healthcare | Drug Manufacturers - General | 2.06% |
| UTHR | United Therapeutics Corporation | Healthcare | Biotechnology | 1.64% |
| SNY | Sanofi ADR | Healthcare | Drug Manufacturers - General | 1.53% |
| NBIX | Neurocrine Biosciences Inc | Healthcare | Drug Manufacturers - Specialty & Generic | 1.44% |
| INCY | Incyte Corporation | Healthcare | Biotechnology | 1.40% |
| RPRX | Royalty Pharma Plc | Healthcare | Biotechnology | 1.38% |
| VTRS | Viatris Inc | Healthcare | Drug Manufacturers - Specialty & Generic | 1.35% |
| SMMT | Summit Therapeutics PLC | Healthcare | Biotechnology | 1.34% |
| ITCI | Intracellular Th | Healthcare | Drug Manufacturers - Specialty & Generic | 1.34% |
| KRTX | Karuna Therapeutics Inc | Healthcare | Biotechnology | 1.31% |
| INSM | Insmed Inc | Healthcare | Biotechnology | 1.30% |
| MRNA | Moderna Inc | Healthcare | Biotechnology | 1.30% |